OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
MediumReport
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Orthofix Medical Inc. (NASDAQ: OFIX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $22.00 price target on the stock, up previously from $20.00.
LowReport
Orthofix Medical Inc. (NASDAQ: OFIX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $22.00 price target on the stock, up previously from $20.00.
Orthofix Medical Inc. (NASDAQ: OFIX) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $18.00.
LowReport
Orthofix Medical Inc. (NASDAQ: OFIX) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $18.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: